Minnesota physicians required to e-prescribe

2 September 2007

Minnesota has announced plans to make it the first US state to require that all prescriptions its employees are written use a paper-less system. Previously, the 50 states have adopted regulations allowing health care providers to adopt e-prescribing technology and many are opting for prescription databases in order to track suspicious drug purchasing associated with prescription drug abuse (Marketletters passim).

The Pharmaceutical Care Management Association has welcomed the move. Mark Merritt, the group's president, said: "Governor [Tim] Pawlenty's Administration is the first to make sure that more doctors take advantage of the safety and savings benefits of e-prescribing. This is a refreshing antidote to the 'all talk, no action' approach that too often accompanies this important issue."

The PCMA, which represents pharmacy benefit managers covering 210 million US residents, argues that e-prescribing reduces the incidence of harmful interactions between drugs and errors caused by illegible prescriptions. The group is campaigning for a nationwide adoption of e-prescribing, quoting a study by the Gorman Health Group, which estimated that it could lead to 1.9 million fewer medical errors and billions of dollars in savings over the next decade.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight